YMAB Historical Earnings image   This YMAB historical earnings page last updated 3/13/2024
YMAB Historical Revenue
PeriodHistorical Earnings DateGAAP
Q4 20232/29/20240.02B
Q3 202311/13/20230.02B
Q2 20238/10/20230.02B
Q1 20235/8/20230.02B
Q4 20223/30/20230.03B
Q3 202211/7/20220.01B
Q2 20228/8/20220.01B
Q1 20225/9/20220.01B
Q4 20212/24/20220.01B
Q3 202111/4/20210.01B
Q2 20218/5/20210.01B
Q1 20215/6/20210.01B
Q4 20202/25/20210.02B
Q3 202011/5/2020NA
Q2 20208/6/2020NA
Q1 20205/7/2020NA
Q4 20193/12/2020NA
Q3 201911/13/2019NA
Q2 20198/14/2019NA
Q1 20195/10/2019NA
Q4 20183/22/2019NA
Q3 201811/13/2018NA
YMAB Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q4 20232/29/2024-0.020
Q3 202311/13/2023-0.180
Q2 20238/10/2023-0.140
Q1 20235/8/2023-0.150
Q4 20223/30/20230.030
Q3 202211/7/2022-0.630
Q2 20228/8/2022-0.940
Q1 20225/9/2022-0.640
Q4 20212/24/2022-0.850
Q3 202111/4/2021-0.660
Q2 20218/5/2021-0.530
Q1 20215/6/20210.750
Q4 20202/25/2021-0.480
Q3 202011/5/2020-0.820
Q2 20208/6/2020-1.010
Q1 20205/7/2020-0.660
Q4 20193/12/2020-0.610
Q3 201911/13/2019-0.700
Q2 20198/14/2019-0.530
Q1 20195/10/2019-0.470
Q4 20183/22/2019-0.42
Q3 201811/13/2018-0.42
Quotes delayed 20 minutes

Email EnvelopeFree YMAB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Y-mAbs Therapeutics (YMAB) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

YMTX Historical Earnings
YTEN Historical Earnings
ZBH Historical Earnings
ZGNX Historical Earnings
ZIMV Historical Earnings
ZIOP Historical Earnings
ZNTL Historical Earnings
ZSAN Historical Earnings
ZTS Historical Earnings
ZVRA Historical Earnings
What was the record high YMAB historical earnings result?
In terms of earnings or revenue, what is the best YMAB historical earnings result that Y-mAbs Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest YMAB historical earnings result was set in Q1 2021, when Y-mAbs Therapeutics posted results of 0.750/share. The most successful revenue quarter within our data set was Q4 2022 when Y-mAbs Therapeutics reported revenue of 0.03B.

What was the lowest Y-mAbs Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest YMAB has reported, and when?

✔️Accepted answer: Within our data set, the lowest YMAB historical earnings result was set in Q2 2020, when Y-mAbs Therapeutics posted results of -1.010/share. The smallest revenue quarter within our data set was Q3 2020 when Y-mAbs Therapeutics reported revenue of NA.

On this page we presented the YMAB historical earnings date information for Y-mAbs Therapeutics. Reviewing that YMAB Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2021, when YMAB posted gaap of 0.750/share. Meanwhile the lowest YMAB historical earnings result was in Q2 2020, when YMAB posted gaap of -1.010/share. Moving to Y-mAbs Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2022 when YMAB reported 0.03B in revenue, while the smallest revenue quarter was Q3 2020 when YMAB reported NA in revenue.

For self directed investors doing their due diligence on YMAB or any other given stock, their research can benefit from looking into all of the Y-mAbs Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Y-mAbs Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for YMAB. Thanks for visiting, and the next time you need to research YMAB historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: LON Videos, Top Ten Hedge Funds Holding US, PUMP Stock Predictions.

 

YMAB Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.